Categories: News

RIMAN Connects APAC Markets in Macau Through Strategy, Innovation, and New Product Reveal

SEOUL, South Korea, April 23, 2026 /PRNewswire/ — RIMAN, a direct selling company prioritizing K-beauty skincare and wellness, successfully concluded its “2026 RIMAN Convention Macau” from April 17th to 19th at The Londoner Macao, bringing together around 2,000 members and leaders from seven Asia-Pacific markets.

- Advertisement -

The event, held under the theme “MADE DIFFERENT,” marked the company’s second regional convention and included participants from South Korea, Taiwan region, Hong Kong SAR, Malaysia, Singapore, the Philippines, and Japan. The three-day program focused on leadership training, business strategy, and product innovation, as the company seeks to strengthen its regional network and expand its global presence.

- Advertisement -

Executives and regional leaders emphasized aligning local execution with global strategy, sharing case studies from different markets. Building on these shared insights, a leadership panel talk and new product reveal followed, bringing the atmosphere to its peak. In particular, RIMAN’s heritage ingredient, Giant BYoungPool™, was revisited as a symbol of the company’s brand philosophy, resonating strongly with participants.

- Advertisement -

RIMAN also highlighted its research pipeline during the event. Dr. Hee-sik Kim, CTO of ASK LABS and a researcher at the Korea Research Institute of Bioscience and Biotechnology, introduced a plant-based bio-material derived from a proprietary chlorella strain found in Jeju. This material has been under development for approximately a decade, with an investment of KRW 3.9 billion (approx. $3.0M). It contains carotenoids such as lutein and zeaxanthin and is set to debut in new products later this year. The venue also included exhibition areas featuring the company’s brands —ICD, botalab, and Lifening—as well as digital installations showcasing its production and sourcing operations in Jeju.

- Advertisement -

Youngsu Hwang, Global Chief Sales Officer, said the goal of the convention is to strengthen coordination across markets and support long-term growth.

- Advertisement -

About RIMAN

- Advertisement -

Founded in 2018 in South Korea, RIMAN is a global beauty and wellness direct-selling company redefining K-Beauty through heritage ingredients from Jeju Island and cutting-edge innovation. At its Jeju Smart Farm, RIMAN manages every step, from raw material cultivation to product development, including its signature ingredient, Giant BYoungPool™—an advanced Centella Asiatica cultivar granted 20-year Plant Variety Protection by the Korea Forest Service in July 2022 and the U.S. Department of Agriculture (USDA) in September 2025.

- Advertisement -

Photo – https://mma.prnewswire.com/media/2964115/DSC5247.jpg
Logo – https://mma.prnewswire.com/media/2780542/RIMAN_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/riman-connects-apac-markets-in-macau-through-strategy-innovation-and-new-product-reveal-302751713.html

- Advertisement -

Recent Posts

THE ROYAL MINT SHINES A LIGHT ON PINK FLOYD WITH FIRST EVER UK COMMEMORATIVE COIN

LLANTRISANT, Wales, May 14, 2026 /PRNewswire/ -- More than half a century since Pink Floyd…

4 hours ago

Frost & Sullivan Explores the Rise of the “Healthspan Economy” and Emerging Growth Opportunities in Nutraceuticals

New whitepaper highlights how healthy aging, women's health, and metabolic wellness are reshaping the future…

4 hours ago

TDFM Inffrastructure Limited Commissions BPCL’s City Gate Station at Khanipur; Secures Prestigious Award for Construction Excellence

GORAKHPUR, India, May 13, 2026 /PRNewswire/ -- TDFM Inffrastructure Limited ("TDFM"), an EPC specialist in…

4 hours ago

Aptose Reports First Quarter 2026 Results

SAN DIEGO and TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or…

7 hours ago

Management teams 2025 market-based Options have vested

NEW HAVEN, Conn., May 13, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO)…

7 hours ago

ZyVersa Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

ZyVersa is advancing a highly differentiated pipeline focusing on inflammatory and renal diseases with a…

7 hours ago